Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Serena Sava"'
Autor:
Michela Campolo, Sarah Adriana Scuderi, Alessia Filippone, Valentina Bova, Sofia Paola Lombardo, Lorenzo Colarossi, Serena Sava, Anna Paola Capra, Federica De Gaetano, Marco Portelli, Angela Militi, Emanuela Esposito, Irene Paterniti
Publikováno v:
Pharmaceuticals, Vol 17, Iss 8, p 1102 (2024)
Oral squamous cell carcinoma (OSCC) is one of the most common human malignancies worldwide. The molecular mechanisms of OSCC pathogenesis are still unknown; however, in recent years, several reports have focused on the role of enhancer of zeste homol
Externí odkaz:
https://doaj.org/article/cbc25b022539435f825f81c09caa1975
Publikováno v:
Journal of Cancer Rehabilitation, Vol 3, Iss 1, Pp 18-19 (2020)
Dear Editor, To date, there is scarce evidence in the scientific literature from which we might generalize regarding the psychological fallout of the COVID-19 pandemic among healthcare professionals. It is evident from daily clinical experience
Externí odkaz:
https://doaj.org/article/0debf4acb18c400fb3eab035bd3229f5
Autor:
Sarah Adriana Scuderi, Alessia Filippone, Rossella Basilotta, Deborah Mannino, Giovanna Casili, Anna Paola Capra, Giulia Chisari, Lorenzo Colarossi, Serena Sava, Michela Campolo, Emanuela Esposito, Irene Paterniti
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 22; Pages: 13915
Glioblastoma (GB) is a tumor of the central nervous system characterized by high proliferation and invasiveness. The standard treatment for GB includes radiotherapy and chemotherapy; however, new therapies are needed. Particular attention was given t
Autor:
Gianluca Ferini, Valentina Zagardo, Paola Critelli, Anna Santacaterina, Serena Sava, Mandara Muralidhar Harikar, Tejas Venkataram, Giuseppe Emmanuele Umana, Anna Viola, Vito Valenti, Stefano Forte
Publikováno v:
Journal of Personalized Medicine. 13:841
Purpose: To investigate the ability of radiotherapy (RT) to prolong progression-free survival (PFS) and to report treatment-related toxicities among oligoprogressive metastatic Merkel cell carcinoma (mMCC) patients on avelumab. Methods: We retrospect
Autor:
Maria V. Sanò, Federica Martorana, Giuseppe Lavenia, Rosalba Rossello, Angela Prestifilippo, Serena Sava, Giuseppina R Ricciardi, Paolo Vigneri
Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors abemaciclib, palbociclib, and ribociclib radically modified the treatment of hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer. Ribociclib efficacy was proved in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11390e2694fe600859738719875572cf
https://hdl.handle.net/20.500.11769/539859
https://hdl.handle.net/20.500.11769/539859
Autor:
Giuseppe Roberto Giammalva, Lara Brunasso, Federica Paolini, Roberta Costanzo, Lapo Bonosi, Umberto Emanuele Benigno, Gianluca Ferini, Serena Sava, Cristina Colarossi, Giuseppe Emmanuele Umana, Rosa Maria Gerardi, Carmelo Lucio Sturiale, Alessio Albanese, Domenico Gerardo Iacopino, Rosario Maugeri
Publikováno v:
Cancers. 14:3639
The role of immunotherapy is gaining ever-increasing interest in the neuro-oncological field, and this is also expanding to the management of intracranial meningioma. Meningiomas are still the most common primary adult tumor of the CNS, and even thou
Autor:
Michela Campolo, Alessio Ardizzone, Serena Sava, Salvatore Cuzzocrea, Stefano Forte, Emanuela Esposito, Giovanna Casili, Sarah Adriana Scuderi, Irene Paterniti, Lorenzo Colarossi
Publikováno v:
Cancers
Volume 13
Issue 14
Cancers, Vol 13, Iss 3444, p 3444 (2021)
Volume 13
Issue 14
Cancers, Vol 13, Iss 3444, p 3444 (2021)
Simple Summary Glioblastoma (GB) is the most aggressive brain tumor characterized by necrosis, excessive proliferation, and invasiveness. Despite relevant progress in conventional treatments, the survival rate for patients with GB remains low. The pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcbbb36469d94f30f043f9376c4b1064
http://hdl.handle.net/11570/3210788
http://hdl.handle.net/11570/3210788
Autor:
Fabio Raiti, Alessandra Battaglia, Vincenzo Adamo, Maria Picciotto, Giuseppe Toscano, Serena Sava, Antonio Russo, A. Scimone
Publikováno v:
Annals of Oncology. 28:vi61
Nivolumab (N) is a novel therapeutic option in NSCLC, with a significant survival gain compared with Docetaxel (D). However, predictive biomarkers are lacking and no strategies have been adopted to date for optimal patients (pts) selection. The prese
Autor:
Giuseppe Toscano, Fabio Raiti, A. Scimone, Maria Picciotto, Alessandro Russo, Vincenzo Adamo, Alessandra Battaglia, Serena Sava
Publikováno v:
Journal of Clinical Oncology. 35:e14617-e14617
e14617 Background: Nivo is a novel therapeutic option in 2nd line NSCLC. However, predictive biomarkers are lacking. The presence of systemic inflammation correlated with poor outcome in many cancer types, including NSCLC. We aimed to evaluate whethe
Autor:
Nadiya V. Yerich, Carolina Alvarez, Todd A. Schwartz, Serena Savage‐Guin, Jordan B. Renner, Catherine J. Bakewell, Minna J. Kohler, Janice Lin, Jonathan Samuels, Amanda E. Nelson
Publikováno v:
ACR Open Rheumatology, Vol 2, Iss 7, Pp 438-448 (2020)
Objective This study sought to develop and employ a comprehensive and standardized ultrasound (US) protocol and scoring atlas for the evaluation of features relevant to knee osteoarthritis (KOA) in a community‐based cohort in the United States, wit
Externí odkaz:
https://doaj.org/article/6e65802bb41b4d1cae0021cf1743f308